Table 7.
Protein | Mean Change (±SD) | Minimum | Maximum | p-Value |
---|---|---|---|---|
Untreated baseline and untreated follow-up | ||||
TRAIL | −0.16 ± 0.19 | −0.61 | 0.08 | 0.014 |
Untreated baseline and treated follow-up | ||||
EGF | −0.92 ± 0.85 | −2.21 | 0.85 | 0.003 |
TNFSF14 | −0.75 ± 0.86 | −1.87 | 1.47 | 0.011 |
CD40-L | −0.67 ± 0.72 | −1.88 | 0.59 | 0.011 |
CASP-8 | −0.64 ± 0.56 | −1.58 | 0.16 | 0.003 |
FGF2 | −0.56 ± 0.45 | −1.22 | 0.3 | 0.002 |
CCL3 | −0.4 ± 0.38 | −1.02 | 0.13 | 0.001 |
IL6 | −0.35 ± 0.5 | −1.47 | 0.25 | 0.033 |
MUC−16 | −0.29 ± 0.38 | −1.2 | 0.3 | 0.013 |
CD244 | −0.27 ± 0.2 | −0.58 | 0.14 | 0.001 |
GZMA | −0.27 ± 0.28 | −0.77 | 0.14 | 0.003 |
CD40 | −0.26 ± 0.12 | −0.46 | −0.03 | 0.0002 |
LAMP3 | −0.26 ± 0.37 | −0.86 | 0.32 | 0.04 |
MCP-2 | −0.25 ± 0.28 | −0.95 | 0.07 | 0.006 |
KLRD1 | −0.25 ± 0.24 | −0.59 | 0.19 | 0.003 |
VEGFR-2 | −0.24 ± 0.11 | −0.41 | −0.08 | 0.0002 |
IL18 | −0.24 ± 0.29 | −0.71 | 0.22 | 0.013 |
CCL4 | −0.23 ± 0.24 | −0.67 | 0.27 | 0.006 |
ADA | −0.22 ± 0.22 | −0.53 | 0.3 | 0.011 |
TWEAK | −0.21 ± 0.15 | −0.44 | 0.01 | 0.0005 |
CD28 | −0.21 ± 0.27 | −0.69 | 0.25 | 0.017 |
MIC-A/B | −0.21 ± 0.23 | −0.59 | 0.15 | 0.005 |
CCL23 | −0.19 ± 0.28 | −0.66 | 0.34 | 0.04 |
TIE2 | −0.18 ± 0.12 | −0.42 | 0 | 0.0005 |
FASLG | −0.17 ± 0.13 | −0.45 | 0 | 0.0005 |
TRAIL | −0.14 ± 0.21 | −0.62 | 0.14 | 0.022 |
KIR3DL1 | −0.14 ± 0.18 | −0.45 | 0.15 | 0.017 |
ICOSLG | −0.1 ± 0.15 | −0.3 | 0.17 | 0.04 |
PD-L2 | −0.1 ± 0.17 | −0.34 | 0.32 | 0.048 |
TNFRSF21 | −0.08 ± 0.13 | −0.33 | 0.17 | 0.027 |
IL10 | 0.21 ± 0.32 | −0.39 | 0.75 | 0.033 |
Treated baseline and treated follow-up | ||||
FGF2 | −0.31 ± 0.28 | −0.83 | 0.08 | 0.003 |
CD28 | −0.09 ± 0.15 | −0.32 | 0.11 | 0.043 |
CD244 | −0.08 ± 0.12 | −0.23 | 0.12 | 0.027 |
ICOSLG | −0.06 ± 0.09 | −0.2 | 0.14 | 0.043 |
CD8A | 0.18 ± 0.19 | −0.11 | 0.58 | 0.009 |
MMP12 | 0.27 ± 0.45 | −0.68 | 1.05 | 0.043 |
GZMB | 0.33 ± 0.47 | −0.12 | 1.37 | 0.021 |
PTN | 0.53 ± 0.53 | −0.42 | 1.28 | 0.007 |